Disability-adjusted life year for<unk> s per 100,000 inhabitants in 2004 Worldwide,<unk>  affects nearly 15% or approximately one billion people. It is more common in women at 19% than men at 11%. In the United States, about 6% of men and 18% of women experience a<unk>  attack in a given year, with a lifetime risk of about 18% and 43% respectively. In Europe,<unk> s affect 12–28% of people at some point in their lives with about 6–15% of adult men and 14–35% of adult women getting at least one yearly. Rates of<unk>  are slightly lower in Asia and Africa than in Western countries. Chronic<unk>  occurs in approximately 1.4 to 2.2% of the population. These figures vary substantially with age: onset of<unk>  is most commonly between 15 and 24 years of age, and occur most frequently in those 35 to 45 years of age. In children, about 1.7% of 7 year olds and 3.9% of those between 7 and 15 experience<unk> , with the condition being slightly more common in boys before puberty. Children as young as two years may be affected. During adolescence,<unk>  becomes more common among women and this persists for the rest of the lifespan, being twice as common among elderly females than males. In women<unk>  without aura are more common than<unk>  with aura; however in men the two types occur with similar frequency. During perimenopause symptoms often get worse before decreasing in severity. While symptoms resolve in about two thirds of the elderly, in 3 to 10% they persist.
Migraine
Cluster headache
Lupus headache
Subarachnoid hemorrhage
Tension headache
Sinusitis
External compression headache
Brain tumor